LONDON, ONTARIO--(Marketwired - Feb. 26, 2014) - Sernova Corp. (TSX VENTURE:SVA), a clinical stage company developing medical technologies for the long-term treatment of chronic debilitating metabolic diseases including diabetes and haemophilia is pleased to announce that it will hold an annual general and special meeting of shareholders (the "AGM") on April 28, 2014. The record date for shareholders entitled to vote at the AGM is March 24, 2014.
Help employers find you! Check out all the jobs and post your resume.
